AVTX icon

Avalo Therapeutics

9 hedge funds and large institutions have $2.37M invested in Avalo Therapeutics in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
AC
1
Armistice Capital
New York
$1.94M +$1.94M +1,175 New
NMC
2
NEA Management Company
Maryland
$341K
Vanguard Group
3
Vanguard Group
Pennsylvania
$34K +$1.7K +1 +5%
VKH
4
Virtu KCG Holdings
New York
$23K -$1.64K -1 -7%
Bank of New York Mellon
5
Bank of New York Mellon
New York
$14K +$14K +9 New
Citadel Advisors
6
Citadel Advisors
Florida
$10K +$10K +6 New
Commonwealth Equity Services
7
Commonwealth Equity Services
Massachusetts
$7K
BlackRock
8
BlackRock
New York
$2K
TWA
9
TCI Wealth Advisors
Arizona
$2K
UBS Group
10
UBS Group
Switzerland
-$9K -5 Closed